/PRNewswire/ DP Technology, an "AI for Science" new paradigm-driven company, today announced the nomination of DPT0218, a novel small molecule targeting Kv1..
New research has major implications for controlling t cell activity: How a supposed 'nuclear' receptor makes TCR signaling possible sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.
“Understanding the role of this receptor has such major implications for studying protective immunity, anticancer therapies, autoimmune disease, and neurological diseases."
Recent pressure to maximize vaccine efficacy has stirred up many new discoveries within immunology, revealing numerous paradigms with untapped therapeutic potential.